| Pure Flow Processing, Sales | Number of Estimates | | 9 | 9 | 9 |
| Pure Flow Processing, Sales | Highest | | 2,034.0 | 2,133.0 | 2,235.0 |
| Pure Flow Processing, Sales | Consensus (Mean) | 1,953.1 | 2,023.9 | 2,108.6 | 2,197.3 |
| Pure Flow Processing, Sales | Median | | 2,027.3 | 2,103.7 | 2,190.9 |
| Pure Flow Processing, Sales | Lowest | | 2,010.0 | 2,091.0 | 2,167.4 |
| Pure Flow Processing, EBITDA before restructuring | Number of Estimates | | 8 | 8 | 8 |
| Pure Flow Processing, EBITDA before restructuring | Highest | | 559.7 | 597.0 | 630.0 |
| Pure Flow Processing, EBITDA before restructuring | Consensus (Mean) | 522.4 | 550.5 | 581.0 | 610.2 |
| Pure Flow Processing, EBITDA before restructuring | Median | | 548.9 | 579.0 | 609.2 |
| Pure Flow Processing, EBITDA before restructuring | Lowest | | 540.9 | 566.6 | 593.9 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Number of Estimates | | 8 | 8 | 8 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Highest | | 27.6 | 28.1 | 28.3 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Consensus (Mean) | 26.7 | 27.2 | 27.6 | 27.8 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Median | | 27.1 | 27.5 | 27.6 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Lowest | | 26.9 | 27.1 | 27.3 |
| Nutrition Plant Engineering, Sales | Number of Estimates | | 9 | 9 | 9 |
| Nutrition Plant Engineering, Sales | Highest | | 2,111.4 | 2,248.6 | 2,383.6 |
| Nutrition Plant Engineering, Sales | Consensus (Mean) | 1,954.6 | 2,076.2 | 2,191.0 | 2,298.5 |
| Nutrition Plant Engineering, Sales | Median | | 2,091.9 | 2,206.0 | 2,306.0 |
| Nutrition Plant Engineering, Sales | Lowest | | 1,995.0 | 2,074.0 | 2,157.0 |
| Nutrition Plant Engineering, EBITDA before restructuring | Number of Estimates | | 8 | 8 | 8 |
| Nutrition Plant Engineering, EBITDA before restructuring | Highest | | 253.0 | 279.8 | 309.3 |
| Nutrition Plant Engineering, EBITDA before restructuring | Consensus (Mean) | 222.4 | 245.6 | 265.9 | 285.3 |
| Nutrition Plant Engineering, EBITDA before restructuring | Median | | 247.3 | 265.1 | 285.9 |
| Nutrition Plant Engineering, EBITDA before restructuring | Lowest | | 229.7 | 252.0 | 262.1 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Number of Estimates | | 8 | 8 | 8 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Highest | | 12.0 | 12.5 | 13.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Consensus (Mean) | 11.4 | 11.8 | 12.1 | 12.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Median | | 11.9 | 12.0 | 12.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Lowest | | 11.4 | 11.7 | 11.8 |
| Pharma & Food Applications, Sales | Number of Estimates | | 9 | 9 | 9 |
| Pharma & Food Applications, Sales | Highest | | 1,132.0 | 1,200.0 | 1,260.0 |
| Pharma & Food Applications, Sales | Consensus (Mean) | 1,058.3 | 1,112.5 | 1,167.8 | 1,221.3 |
| Pharma & Food Applications, Sales | Median | | 1,116.2 | 1,172.4 | 1,224.0 |
| Pharma & Food Applications, Sales | Lowest | | 1,084.2 | 1,127.6 | 1,172.7 |
| Pharma & Food Applications, EBITDA before restructuring | Number of Estimates | | 8 | 8 | 8 |
| Pharma & Food Applications, EBITDA before restructuring | Highest | | 164.0 | 179.0 | 194.0 |
| Pharma & Food Applications, EBITDA before restructuring | Consensus (Mean) | 140.7 | 155.9 | 168.1 | 179.7 |
| Pharma & Food Applications, EBITDA before restructuring | Median | | 157.0 | 170.8 | 182.9 |
| Pharma & Food Applications, EBITDA before restructuring | Lowest | | 148.5 | 156.7 | 164.2 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Number of Estimates | | 8 | 8 | 8 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Highest | | 14.5 | 14.9 | 15.4 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Consensus (Mean) | 13.3 | 14.0 | 14.3 | 14.7 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Median | | 14.0 | 14.4 | 14.7 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Lowest | | 13.4 | 13.7 | 13.8 |
| Farm Technologies, Sales | Number of Estimates | | 9 | 9 | 9 |
| Farm Technologies, Sales | Highest | | 821.0 | 854.4 | 891.7 |
| Farm Technologies, Sales | Consensus (Mean) | 763.4 | 799.6 | 831.5 | 865.7 |
| Farm Technologies, Sales | Median | | 796.0 | 830.4 | 871.9 |
| Farm Technologies, Sales | Lowest | | 780.0 | 795.6 | 819.5 |
| Farm Technologies, EBITDA before restructuring | Number of Estimates | | 8 | 8 | 8 |
| Farm Technologies, EBITDA before restructuring | Highest | | 130.7 | 139.6 | 150.9 |
| Farm Technologies, EBITDA before restructuring | Consensus (Mean) | 113.0 | 123.4 | 130.8 | 140.4 |
| Farm Technologies, EBITDA before restructuring | Median | | 122.5 | 130.3 | 141.6 |
| Farm Technologies, EBITDA before restructuring | Lowest | | 119.0 | 124.1 | 130.1 |
| Farm Technologies, EBITDA before restructuring margin in % | Number of Estimates | | 8 | 8 | 8 |
| Farm Technologies, EBITDA before restructuring margin in % | Highest | | 16.5 | 16.8 | 17.7 |
| Farm Technologies, EBITDA before restructuring margin in % | Consensus (Mean) | 14.8 | 15.5 | 15.8 | 16.3 |
| Farm Technologies, EBITDA before restructuring margin in % | Median | | 15.3 | 15.5 | 16.1 |
| Farm Technologies, EBITDA before restructuring margin in % | Lowest | | 14.8 | 14.8 | 14.9 |
| Consolidation/Other, Sales | Number of Estimates | | 9 | 9 | 9 |
| Consolidation/Other, Sales | Highest | | -180.0 | -220.0 | -215.0 |
| Consolidation/Other, Sales | Consensus (Mean) | -234.0 | -230.9 | -240.6 | -244.7 |
| Consolidation/Other, Sales | Median | | -234.0 | -240.0 | -240.0 |
| Consolidation/Other, Sales | Lowest | | -250.0 | -260.0 | -280.0 |
| Consolidation/Other, EBITDA before restructuring | Number of Estimates | | 8 | 8 | 8 |
| Consolidation/Other, EBITDA before restructuring | Highest | | -83.0 | -85.0 | -75.0 |
| Consolidation/Other, EBITDA before restructuring | Consensus (Mean) | -91.1 | -92.0 | -90.8 | -91.5 |
| Consolidation/Other, EBITDA before restructuring | Median | | -89.0 | -90.2 | -91.0 |
| Consolidation/Other, EBITDA before restructuring | Lowest | | -105.0 | -105.0 | -109.0 |